Herbal product, sold as weight loss supplement, contains unlisted active pharmaceutical ingredients. Risk of serious side effects, especially in those with heart conditions.
(BioMed Central) Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, Oct. 20-22, 2010.
(University of Manchester) A major conference, organized by scientists at the University of Manchester to showcase vital work on the effect of geographic chemicals, begins today.
Nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating riskJuly 8, 2010 10:39 am | by I-Micronews | News | Comments
Nanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015.
The thinnest, smoothest metallic lines in the world helps speed up miniaturisation of electronic devicesJuly 8, 2010 10:39 am | by I-Micronews | News | Comments
New method creates super-thin, high integrity, continuous metal lines that surpass today?s semiconductor industry requirements.
Nichia Corp will finally commercialize its green diode laser for use mainly in pico projectors.
Genzyme Corp. is expanding a deal designed to transfer more so-called fill-finish manufacturing work to Hospira Worldwide Inc. â€“ part of an agreement with the U.S. FDA to comply with an enforcement action against the Cambridge-based biotechnology company.
PALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBladeÂ® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...
Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in ParisJuly 8, 2010 10:37 am | by Bio-Medicine.Org | News | Comments
PARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...
Free license gives access to 24,544 terms, including genetic testing and device software PLYMOUTH MEETING, Pa. , July 8 /PRNewswire-USNewswire/ -- ECRI Institute's Universal Medical Device Nomenclature System™, the most comprehensive medical device taxonomy, announces the...
ALBUQUERQUE, N.M. , July 8 /- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading...
Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactionsJuly 8, 2010 10:31 am | by U.S. Food & Drug Administration | News | Comments
New Risk Management Plan. Reports of serious side effects in patients using Qualaquin "off-label" for night time leg cramps.
The MDT community forum is a great location to discuss new trends, share tips, give opinions, and exchange ideas.
These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for January 2010
Federal Register: Guidance for Humanitarian Device Exemption Holders, Institutional Review Boards, Clinical Investigators, and Food and Drug Administration Staff; Humanitarian...July 8, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments
This guidance answers commonly asked questions about Humanitarian Use Devices (HUDs) and applications for HDEs.